Bicher A[au] - Search Results

Year	Number of Results
1993	3
1994	3
1995	2
1997	1
2000	2
2014	1
2015	1
2020	1
2024	0

1

Urinary symptoms in women receiving carboplatin/paclitaxel for treatment of gynecologic cancers.

Strauchon CJ, Dengler KL, Gruber DD, Katebi Kashi P, Aungst MJ, Trikhacheva A, Bicher A, Von Pechmann W. Strauchon CJ, et al. Among authors: bicher a. Int J Gynecol Cancer. 2020 Sep;30(9):1418-1423. doi: 10.1136/ijgc-2020-001529. Epub 2020 Jul 12. Int J Gynecol Cancer. 2020. PMID: 32655011

2

Dose-intense taxol: high response rate in patients with platinum-resistant recurrent ovarian cancer.

Kohn EC, Sarosy G, Bicher A, Link C, Christian M, Steinberg SM, Rothenberg M, Adamo DO, Davis P, Ognibene FP, et al. Kohn EC, et al. Among authors: bicher a. J Natl Cancer Inst. 1994 Jan 5;86(1):18-24. doi: 10.1093/jnci/86.1.18. J Natl Cancer Inst. 1994. PMID: 7505830 Clinical Trial.

3

Metastatic choriocarcinoma presenting in a gravid woman.

Byrd K, Seay R, Bechert CJ, Maxwell GL, Bicher A. Byrd K, et al. Among authors: bicher a. Gynecol Obstet Invest. 2015;79(4):276-9. doi: 10.1159/000363234. Epub 2014 Nov 19. Gynecol Obstet Invest. 2015. PMID: 25412690

4

Infusion site soft-tissue injury after paclitaxel administration.

Bicher A, Levenback C, Burke TW, Morris M, Warner D, DeJesus Y, Gershenson DM. Bicher A, et al. Cancer. 1995 Jul 1;76(1):116-20. doi: 10.1002/1097-0142(19950701)76:1<116::aid-cncr2820760118>3.0.co;2-p. Cancer. 1995. PMID: 8630862

5

Metastatic cervical cancer presenting as cholecystitis.

Bicher A, Sahin AA, Burke TW. Bicher A, et al. Gynecol Oncol. 1994 Aug;54(2):250-3. doi: 10.1006/gyno.1994.1203. Gynecol Oncol. 1994. PMID: 8063256

6

Ovarian malignant mixed müllerian tumors treated with platinum-based chemotherapy.

Bicher A, Levenback C, Silva EG, Burke TW, Morris M, Gershenson DM. Bicher A, et al. Obstet Gynecol. 1995 May;85(5 Pt 1):735-9. doi: 10.1016/0029-7844(95)00038-s. Obstet Gynecol. 1995. PMID: 7724104

7

Analysis of autopsy evaluations of ovarian cancer patients treated at the National Cancer Institute, 1972-1988.

Reed E, Zerbe CS, Brawley OW, Bicher A, Steinberg SM. Reed E, et al. Among authors: bicher a. Am J Clin Oncol. 2000 Apr;23(2):107-16. doi: 10.1097/00000421-200004000-00002. Am J Clin Oncol. 2000. PMID: 10776968

8

Age does not influence taxol dose intensity in recurrent carcinoma of the ovary.

Bicher A, Sarosy G, Kohn E, Adamo DO, Davis P, Jacob J, Chabner BA, Reed E. Bicher A, et al. Cancer. 1993 Jan 15;71(2 Suppl):594-600. doi: 10.1002/cncr.2820710216. Cancer. 1993. PMID: 7678382 Clinical Trial.

9

Absence of evidence for allelic loss or allelic gain for ERCC1 or for XPD in human ovarian cancer cells and tissues.

Yu JJ, Bicher A, Ma YK, Bostick-Bruton F, Reed E. Yu JJ, et al. Among authors: bicher a. Cancer Lett. 2000 Apr 14;151(2):127-32. doi: 10.1016/s0304-3835(99)00390-0. Cancer Lett. 2000. PMID: 10738106

10

Loss of heterozygosity in human ovarian cancer on chromosome 19q.

Bicher A, Ault K, Kimmelman A, Gershenson D, Reed E, Liang B. Bicher A, et al. Gynecol Oncol. 1997 Jul;66(1):36-40. doi: 10.1006/gyno.1997.4709. Gynecol Oncol. 1997. PMID: 9234918

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

13 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year